Please provide your email address to receive an email when new articles are posted on . Subcutaneous implantable cardioverter defibrillators can be extracted safely and feasibly. S-ICD extraction was ...
SAN FRANCISCO, CA—The subcutaneous implantable cardioverter-defibrillator (S-ICD; Boston Scientific) prevents most of the major lead-related complications seen with a transvenous system, the ATLAS ...
Please provide your email address to receive an email when new articles are posted on . Among patients who received implantable cardioverter defibrillator therapy, a subcutaneous vs. transvenous ...
The subcutaneous implantable cardioverter–defibrillator (ICD) is associated with fewer lead-related complications than a transvenous ICD; however, the subcutaneous ICD cannot provide bradycardia and ...
Though the PRAETORIAN group was technically unable to prove that 8 years was enough to give a subcutaneous implantable cardioverter-defibrillator (ICD) an edge in safety, complication rates helped ...
BOSTON -- A leadless pacemaker reliably communicated with a subcutaneous implantable cardioverter-defibrillator (S-ICD) to deliver anti-tachycardia (ATP) and bradycardia pacing, the MODULAR ATP study ...
Cameron Health, Inc. today announced the publication of study results online in the New England Journal of Medicine (NEJM) highlighting the development and potential benefits of the company's S-ICD® ...
This section describes safety outcomes from the published literature that the committee considered as part of the evidence about this procedure. For more detailed information on the evidence, see the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results